Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹203 Cr
up ₹2.1 Cr vs May 2019
- Stocks held
- 22
- unchanged
- Top 10 weight
- 64.6%
- of the portfolio in its ten largest
- Cash & debt
- 3.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 10
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2019 it disclosed 22 stocks worth ₹203 Cr, up ₹2.1 Cr from May 2019. Its largest positions were Sun Pharmaceutical Industries Limited (13.5%), IPCA Laboratories Limited (9.8%), Dr. Reddy's Laboratories Limited (9.0%); the ten largest together made up 64.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.0% of its equity. Cash and debt stood at 3.5%. Compared with May 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
52%
Holds more cash than 52% of peers
What these mean: concentration · cash
Holdings in June 2019
Download CSVEvery line the fund disclosed, with the change against May 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.50% | up 0.08 pts | ₹27.4 Cr | up ₹44 L | Added |
| IPCA Laboratories Limited | 9.83% | down 0.12 pts | ₹20 Cr | down ₹4 L | Held |
| Dr. Reddy's Laboratories Limited | 8.98% | down 0.55 pts | ₹18.2 Cr | down ₹91 L | Trimmed |
| Divi's Laboratories Limited | 7.09% | up 0.39 pts | ₹14.4 Cr | up ₹94 L | Added |
| Apollo Hospitals Enterprise Limited | 5.39% | up 0.43 pts | ₹11 Cr | up ₹97 L | Added |
| Indoco Remedies Limited | 4.55% | down 0.42 pts | ₹9.3 Cr | down ₹75 L | Trimmed |
| JB Chemicals & Pharmaceuticals Limited | 4.48% | down 0.15 pts | ₹9.1 Cr | down ₹20 L | Trimmed |
| Unichem Laboratories Limited | 3.81% | down 0.50 pts | ₹7.7 Cr | down ₹92 L | Trimmed |
| Cash, TREPS & receivables | 3.52% | down 1.01 pts | ₹7.2 Cr | down ₹2 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 3.51% | up 0.27 pts | ₹7.1 Cr | up ₹61 L | Added |
| Procter & Gamble Health Limited | 3.45% | up 0.50 pts | ₹7 Cr | up ₹1.1 Cr | Added |
| Max India Limited | 3.20% | up 1.02 pts | ₹6.5 Cr | up ₹2.1 Cr | Added |
| Abiomed Inc | 2.92% | down 0.14 pts | ₹5.9 Cr | down ₹21 L | Trimmed |
| Ajanta Pharma Limited | 2.91% | down 0.09 pts | ₹5.9 Cr | down ₹11 L | Trimmed |
| Abbott Laboratories | 2.88% | up 0.20 pts | ₹5.9 Cr | up ₹46 L | Added |
| Syngene International Limited | 2.86% | up 0.06 pts | ₹5.8 Cr | up ₹19 L | Added |
| Alkem Laboratories Limited | 2.86% | down 0.14 pts | ₹5.8 Cr | down ₹23 L | Trimmed |
| Jubilant Pharmova Limited | 2.82% | up 0.22 pts | ₹5.7 Cr | up ₹50 L | Added |
| Aarti Drugs Limited | 2.82% | down 0.19 pts | ₹5.7 Cr | down ₹33 L | Trimmed |
| Abbott India Limited | 2.78% | up 0.32 pts | ₹5.7 Cr | up ₹71 L | Added |
| Torrent Pharmaceuticals Limited | 2.50% | down 0.05 pts | ₹5.1 Cr | down ₹6 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.03% | down 0.14 pts | ₹4.1 Cr | down ₹24 L | Trimmed |
| Dr. Lal Path Labs Limited | 1.29% | up 0.03 pts | ₹2.6 Cr | up ₹8 L | Added |
What changed, May 2019 to Jun 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Max India Limitedup ₹2.1 Cr (+1.02% pts)
- Procter & Gamble Health Limitedup ₹1.1 Cr (+0.50% pts)
- Apollo Hospitals Enterprise Limitedup ₹97 L (+0.43% pts)
- Divi's Laboratories Limitedup ₹94 L (+0.39% pts)
- Abbott India Limited ₹71 L (+0.32% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2019, the weight rose most in Healthcare Services (+1.3 pts), and fell most in Pharmaceuticals (−0.9 pts) and Pharmaceuticals & Biotechnology (−0.2 pts).
- Healthcare Services14.9% → 16.2%+1.3 pts
- Pharmaceuticals12.5% → 11.7%−0.9 pts
- Pharmaceuticals & Biotechnology70.2% → 70.0%−0.2 pts
- Insurance2.3% → 2.1%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2018 | Mar 2019 | May 2019 | Jun 2019 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.9% | 70.6% | 70.2% | 70.0% |
| Healthcare Services | 16.6% | 15.1% | 14.9% | 16.2% |
| Pharmaceuticals | 10.7% | 11.9% | 12.5% | 11.7% |
| Insurance | 2.7% | 2.3% | 2.3% | 2.1% |
Allocation in Jun 2019change vs May 2019
- Pharmaceuticals & Biotechnology (13)70.0%▼ 0.2 pts
- Healthcare Services (5)16.2%▲ 1.3 pts
- Pharmaceuticals (3)11.7%▼ 0.9 pts
- Insurance (1)2.1%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2019
3.5%
▼ 1.0 pts vs May 2019
- Cash alone
- 3.5%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 3.5% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.